Boston An independent LDT provider
OBS:Immunovia har upphört med kommersialiseringen av IMMray PanCan-d-testet. Mer information finns här:

Webinar nr. 3: Verification Study Output

december 17, 2020

Presentationer av: Thomas King, MD, PhD, Linda Mellby, PhD, Laura Chirica, PhD, Immunovia

Moderator: Patrik Dahlen, CEO Immunovia

Immunovia interview with Prof. Stephen Pereira, Gastroenterologist and Hepatologist, BSc, PhD, FRCP, FRCPE, at the London Clinic (UCL), Principle Investigator for Immunovia´s PanSYM study in London, UK, in regard to the clinical utility of diagnostic tests in pancreatic cancer, December 8, 2020.

0:00 Introduction and Agenda
1:40 Positioning of IMMray™ PanCan-d in clinical practice
17:45 Verification study vs clinical practice
26:55 Voice of pancreatic cancer experts about IMMray™ PanCan-d clinical utility
41:22 Q&A Session